日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Weight of Disease, the Loss Within: Rethinking Frailty Assessment in ADPKD

疾病的重负，内在的损失：重新思考ADPKD患者的虚弱评估

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2026.106476
Paolisi, Michele; Bianca, Pierpaolo; De Rosa, Liliana Italia; Catania, Martina; Kola, Kristiana; Pisoni, Matteo Brambilla; Maiucchi, Paola; Vezzoli, Giuseppe; Sciarrone Alibrandi, Maria Teresa
发表日期：2026
文献求助 收藏

Sodium-Glucose Cotransporter-2 Inhibitors in ADPKD: Time to Integrate Cardiovascular Outcomes

ADPKD 中的钠-葡萄糖协同转运蛋白 2 抑制剂：是时候将心血管结局纳入考量了

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2025.103762
Catania, Martina; Rivera, Rodolfo Fernando; Kola, Kristiana; De Rosa, Liliana Italia; Paolisi, Michele; Bianca, Pierpaolo; Vezzoli, Giuseppe; Sciarrone Alibrandi, Maria Teresa
发表日期：2026
文献求助 收藏

The Hidden Iceberg of ADPKD: Early Organomegaly-Driven Malnutrition and Sarcopenia Beyond Preserved eGFR

ADPKD的隐性冰山：早期器官肿大导致的营养不良和肌少症，即使eGFR正常

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms27041667
Brambilla Pisoni, Matteo; Catania, Martina; Rivera, Rodolfo Fernando; De Rosa, Liliana Italia; Kola, Kristiana; Paolisi, Michele; Bianca, Pierpaolo; Farinone, Sara; Petrone, Micaela; Citterio, Lorena; Vezzoli, Giuseppe; Sciarrone Alibrandi, Maria Teresa
发表日期：2026
文献求助 收藏

Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes

优化ADPKD患者托伐普坦的给药方案：尿液生物标志物在改善治疗效果中的作用

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2025.03.059
De Rosa, Liliana Italia; Catania, Martina; Kola, Kristiana; Paolisi, Michele; Bianca, Pierpaolo; Manunta, Paolo; Vezzoli, Giuseppe; Sciarrone Alibrandi, Maria Teresa
发表日期：2025
文献求助 收藏